Loading
Loading
Your feedback directly shapes Sporos.
Sign in to track your feedback history
Experimental Treatments for Terminal Conditions and Life-threatening Rare Diseases; Authorizes licensed physicians to prescribe & eligible facilities to administer experimental treatments; requires approval of specified platform or master protocol by institutional review board; requires DOH to establish & maintain patient registry; requires DOH to annually publish specified report; encourages health insurers & health maintenance organizations to provide specified insurance coverage for experimental treatments; authorizes licensed physicians & eligible facilities to receive reimbursement for experimental treatments; requires manufacturers of experimental treatments to provide for specified temporary price concession; requires DOH to adopt by rule certain procedures for licensing of experimental treatment centers.
Introduced
Jan 13, 2026
Last Action
Jan 15, 2026
Session
FL 2026
Sponsors
1 primary · 0 co
Referred to Health Professions & Programs Subcommittee
Referred to Health Care Budget Subcommittee
Referred to Health & Human Services Committee
Now in Health Professions & Programs Subcommittee
1st Reading (Original Filed Version)
Filed
Get a plain-English explanation of what this bill does, who it affects, and why it matters.
Now in Health Professions & Programs Subcommittee